The prognosis with treatment is generally good and much better than in the classic paraneoplastic syndromes. Patients, in one of the two biggest case series, with anti-CASPR2 antibodies w/o tumours improved in average from a Modified Rankin Score (MRS) of 4 (moderate severe disability) to a MRS of 1 (no significant disability despite symptoms). The patients with anti-CASPR2 antibodies and tumours often deteriorated despite of treatment. The improvements seen in patients with anti-LGI1 antibodies were slightly better.
Anti-VGKC-complex encephalitis
Anti-NMDA receptor encephalitis
Anti-Hu associated encephalitis
Anti-neurofascin demyelinating diseases
Lymphocytic meningoradiculitis
Limbic encephalitis
Powassan encephalitis
Autoimmune encephalitis